| Feature Type | Standardized | Nominal ANOVA | ||||
|---|---|---|---|---|---|---|
| mRNA | foretinib | GDSC1000 | pan-cancer | AAC | -0.079 | 0.05 |
| mRNA | PF-3758309 | CTRPv2 | pan-cancer | AAC | -0.096 | 0.05 |
| mRNA | thapsigargin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | BRD-K24690302 | CTRPv2 | pan-cancer | AAC | -0.08 | 0.05 |
| mRNA | BRD-K99006945 | CTRPv2 | pan-cancer | AAC | -0.11 | 0.05 |
| mRNA | Doxorubicin | GDSC1000 | pan-cancer | AAC | 0.086 | 0.05 |
| mRNA | AM-580 | CTRPv2 | pan-cancer | AAC | -0.083 | 0.05 |
| mRNA | NU-7441 | GDSC1000 | pan-cancer | AAC | 0.084 | 0.06 |
| mRNA | tandutinib | CTRPv2 | pan-cancer | AAC | -0.078 | 0.06 |
| mRNA | CAY10603 | GDSC1000 | pan-cancer | AAC | -0.071 | 0.06 |